Buspirone Hydrochloride

Buspirone Hydrochloride is used to treat anxiety disorders, depressive disorder and intellectual disability, per the National Library of Medicine's MED-RT classification. The brand product was first FDA-approved on Sep 29, 1986, and the first generic was approved Mar 28, 2001. FDA's Orange Book lists 63 AB-rated (therapeutically equivalent) products for this ingredient.

Buspirone Hydrochloride is available as 148 NDCs from 17 manufacturers (148 generic, 0 brand), with NADAC prices from $0.02 to $0.12 per EA — the most expensive product costs about 5.6× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.